These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9007812)

  • 21. Percutaneous pulmonary thrombectomy.
    Lang EV; Barnhart WH; Walton DL; Raab SS
    J Vasc Interv Radiol; 1997; 8(3):427-32. PubMed ID: 9152916
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thrombolytic therapy as pretreatment before vascular operations and radiologic interventions].
    Laczkó A; Szabó GV; Szeberin Z; Nemes B; Bobek I; Kristóf V; Selmeci L; Acsády G
    Magy Seb; 2001 Dec; 54 Suppl():69-73. PubMed ID: 11816152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catheter-directed thrombolysis in a child with acute lymphoblastic leukemia and extensive deep vein thrombosis.
    Savage SA; Young G; Reaman GH
    Med Pediatr Oncol; 2000 Mar; 34(3):215-7. PubMed ID: 10696131
    [No Abstract]   [Full Text] [Related]  

  • 24. Thrombolytic therapy in patients with portal vein thrombosis: case report and review of the literature.
    Schäfer C; Zundler J; Bode JC
    Eur J Gastroenterol Hepatol; 2000 Oct; 12(10):1141-5. PubMed ID: 11057461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
    Korninger C; Matsuo O; Suy R; Stassen JM; Collen D
    J Clin Invest; 1982 Mar; 69(3):573-80. PubMed ID: 7199539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial.
    Goldhaber SZ; Hirsch DR; MacDougall RC; Polak JF; Creager MA
    Am Heart J; 1996 Aug; 132(2 Pt 1):314-8. PubMed ID: 8701892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombolytic therapy of thrombosis].
    Niiya K
    Nihon Naika Gakkai Zasshi; 1997 Jun; 86(6):972-80. PubMed ID: 9340366
    [No Abstract]   [Full Text] [Related]  

  • 28. Regarding "The safety, efficacy and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions".
    Manfredini R; Boari B; Gallerani M; Portaluppi F; Mehta RH
    J Vasc Surg; 2003 Aug; 38(2):411-2. PubMed ID: 12894792
    [No Abstract]   [Full Text] [Related]  

  • 29. Deep venous thrombosis associated with protein C and/or S deficiency: management with catheter-directed thrombolysis.
    Cho YP; Jang HJ; Lee DH; Ahn J; Han MS; Kim JS; Kim YH; Lee SG
    Br J Radiol; 2003 Jun; 76(906):380-4. PubMed ID: 12814923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing venous gangrene in deep vein thrombosis: intraarterial low-dose burst therapy with urokinase--case reports.
    Garg SK; Yadav KS
    Angiology; 1999 Feb; 50(2):157-62. PubMed ID: 10063948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advancement on thrombolytic characteristic, function and clinical application of different fibrinolytic enzymes].
    Sun Y; Wang W; Li C
    Zhongguo Zhong Yao Za Zhi; 2010 Mar; 35(6):794-8. PubMed ID: 20545212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extensive mesenteric vein and portal vein thrombosis successfully treated by thrombolysis and anticoagulation.
    Tateishi A; Mitsui H; Oki T; Morishita J; Maekawa H; Yahagi N; Maruyama T; Ichinose M; Ohnishi S; Shiratori Y; Minami M; Koutetsu S; Hori N; Watanabe T; Nagawa H; Omata M
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1429-33. PubMed ID: 11851847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions.
    Yoon HC; Miller FJ
    AJR Am J Roentgenol; 2002 Mar; 178(3):617-22. PubMed ID: 11856686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound guidance to gain access for the "lyse and wait" technique.
    Mahon BR
    J Vasc Interv Radiol; 1999 Jun; 10(6):833. PubMed ID: 10392957
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulse-spray pharmacomechanical thrombolysis for proximal deep vein thrombosis.
    Elsharawy MA
    Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):604; author reply 604-5. PubMed ID: 16928456
    [No Abstract]   [Full Text] [Related]  

  • 36. [Catheter-guided thrombolysis in peripheral arterial occlusion].
    Lindholt JS; Holt G; Sandermann J
    Ugeskr Laeger; 2001 Nov; 163(48):6734-8. PubMed ID: 11768897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sigmoid sinus thrombosis associated with internal jugular venous occlusion: direct thrombolytic treatment.
    Gurley MB; King TS; Tsai FY
    J Endovasc Surg; 1996 Aug; 3(3):306-14. PubMed ID: 8800235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of coronary thrombolysis with plasminogen pro-activator by pretreatment with heparin.
    Susawa T; Yui Y; Hattori R; Takatsu Y; Yui N; Takahashi M; Aoyama T; Murohara Y; Shirotani M; Kawai C
    Jpn Circ J; 1988 Jan; 52(1):72-8. PubMed ID: 3129601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of thrombolysis.
    Sell JJ; Rupp FW; Telepak RJ
    West J Med; 1996; 165(1-2):53. PubMed ID: 8855686
    [No Abstract]   [Full Text] [Related]  

  • 40. Pulse-spray catheter directed thrombolysis in patients with recent onset or deterioration of lower extremity ischemia.
    Chen YX; Liu CW; Zeng R; Li YJ; Ye W; Shao J
    Chin Med J (Engl); 2012 Jan; 125(2):188-92. PubMed ID: 22340543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.